INTRODUCTION {#s1}
============

Promotion of longevity and in particular extension of healthy lifespan (also named 'healthspan') is of eminent interest to most humans. Specific mutations have been shown to extend the lifespan of model organisms dramatically \[[@R1]-[@R8]\], while more readily available interventions, including calorie restriction, also extend life expectancy of model organisms \[[@R9], [@R10]\].

Accordingly, considerable effort has been invested to identify naturally occurring and/or pharmaceutical compounds that promote longevity in model organisms. A number of such compounds have been identified in recent years, including rapamycin \[[@R11]-[@R15]\], resveratrol \[[@R13], [@R16]-[@R19]\], 2-deoxy-D-glucose \[[@R20]\], lithium \[[@R21], [@R22]\], glaucarubinone \[[@R23]\], lonidamine \[[@R24]\], rotenone \[[@R25]\], and others reviewed elsewhere.

Fibrates are amphipatic carboxylic acids that are used to treat metabolic disorders, primarily hypercholesterolemia and/or hypertriglyceridemia \[[@R26]\]. As lipid-modifying substances they are capable of increasing HDL cholesterol levels and decreasing triglycerides and LDL in plasma \[[@R26]\]. Like certain fatty acids, they are agonists of the peroxisome proliferator activated receptors (PPARs). Activation of PPAR by fibrates leads to increased hydrolysis of triglycerides, stimulation of cellular fatty acid uptake and conversion to acyl-CoA derivatives, decreased synthesis of triglycerides and fatty acids as well as VLDL, and finally increased peroxisomal and mitochondrial beta oxidation \[[@R26]\].

PPARs are nuclear receptors that act as transcription factors. They typically heterodimerize with the retinoic X receptor (RXR) and regulate expression of genes involved in development, metabolism, and cellular differentiation after binding to their respective response elements (PPREs) \[[@R27]\]. PPARs regulate expression of genes involved in intra- and extracellular lipid metabolism, especially genes implicated in beta oxidation \[[@R28]\]. PPARalpha is a master regulator of lipid metabolism. Activation induces the expression of the liver-X-receptor and ACBA1, a transporter that mediates cholesterol efflux from macrophages \[[@R29]\]. Furthermore, it controls adaptive response processes to calorie restriction due to its ability to activate ketogenesis \[[@R30]\].

The nematodal nuclear hormone receptor 49 (NHR-49) has sequence homology to the human hepatocyte nuclear factor 4 (HNF4), but is assumed to act as the functional orthologue of mammalian PPARalpha since it shares most of the biological activities of the latter \[[@R31]\].

In this study we have tested whether various fibrates, namely bezafibrate, clofibrate, and fenofibrate, at pharmaceutical doses may be capable of extending the life span of the nematodal model organism *C. elegans*.

RESULTS {#s2}
=======

Fibrates extend *C. elegans* life span {#s2_1}
--------------------------------------

By continuously exposing nematodes starting at young adult age for their entire lifespan to defined concentrations of three different fibrates, which in mammals serve as ligands for the nuclear receptor PPARalpha, we tested whether and to which extent these compounds affect *C. elegans* lifespan.

Bezafibrate extended nematodal life span at three different concentrations (0.1, 1, and 10 micromolar) (Fig. [1](#F1){ref-type="fig"}). The maximum observable effect on mean life span was 2.8 days which occurred at a concentration of 10 micromolar (pls. see Table [1](#T1){ref-type="table"} for details, also applies to all following life span assays).

![Bezafibrate extends lifespan of adult *C. elegans*\
Life span analyses with several hundred N2 wild type nematodes each at three different concentrations of bezafibrate (0.1, 1, and 10 micromolar) versus control (0.1% DMSO).](aging-05-270-g001){#F1}

###### Results and statistical analyses of life span assays

  Strain               Treatment            Max Life Span in Days ± SD   Mean Life Span in Days ± SD   n         p-Value versus Control   
  -------------------- -------------------- ---------------------------- ----------------------------- --------- ------------------------ --
  N2                   0.1 % DMSO control   28.1 ± 1.5                   21.6 ± 1.2                    11                                 
  clofibrate 0.1 μM    25.9                 22.0                         1                             n\. s.    0.8248                   
  clofibrate 1 μM      27.2                 22.6                         1                             n\. s.    0.1877                   
  clofibrate 10 μM     33.8                 25.1                         1                             \*\*\*    \< 0.0001                
  clofibrate 10 μM     34.2 ± 0.9           23.0 ± 0.5                   3                             \*\*\*    \< 0.0001                
  bezafibrate 0.1 μM   32.0                 23.3                         1                             \*        0.0138                   
  bezafibrate 1 μM     33.1                 22.8                         1                             \*        0.0137                   
  bezafibrate 10 μM    34.4                 22.9                         1                             \*\*      0.0078                   
  bezafibrate 10 μM    32.5 ± 1.8           24.4 ± 0.7                   3                             \*\*\*    0.0002                   
  fenofibrate 0.1 μM   34.6                 22.5                         1                             \*        0.0143                   
  fenofibrate 1 μM     28.8                 22.3                         1                             n\. s.    0.1824                   
  fenofibrate 10 μM    32.8                 25.6                         1                             \*\*\*    \< 0.0001                
  fenofibrate 10 μM    30.2 ± 0.3           23.7 ± 1.1                   3                             \*        0.0218                   
                                                                                                                                          
  *nhr-49*                                                                                                                                
   ok2165              0.1 % DMSO control   17.2 ± 1.2                   12.2 ± 0.4                    3                                  
  bezafibrate 10 μM    17.7 ± 0.8           11.5 ± 0.2                   3                             n\. s.    0.1606                   
  clofibrate 10 μM     15.7 ± 0.4           11.0 ± 0.2                   3                             neg. s.   \< 0.0001                
  fenofibrate 10 μM    13.5 ± 0.2           9.5 ± 0.0                    3                             neg. s.   \< 0.0001                
                                                                                                                                          
   gk405               0.1 % DMSO control   16.7 ± 3.6                   11.0 ± 0.4                    3                                  
  bezafibrate 10 μM    17.7 ± 3.7           11.4 ± 0.8                   3                             n\. s.    0.0679                   
  clofibrate 10 μM     17.5 ± 3.4           11.0 ± 0.3                   3                             n\. s.    0.8962                   
  fenofibrate 10 μM    14.5 ± 1.6           10.8 ± 0.2                   3                             n\. s.    0.3035                   

Clofibrate cause extension of *C. elegans* lifespan at a concentration of 10 micromolar (Fig. [2](#F2){ref-type="fig"}) reflected by a mean life span of 23.0 days equaling an increase of 1.4 days.

![Clofibrate extends lifespan of adult *C. elegans*\
Life span analyses with several hundred N2 wild type nematodes each at three different concentrations of clofibrate (0.1, 1, and 10 micromolar) versus control (0.1% DMSO).](aging-05-270-g002){#F2}

Fenofibrate was capable of promoting life expectancy at concentrations of 0.1 and 10 micomolar (Fig. [3](#F3){ref-type="fig"}) with the most pronounced increase in mean life span at a concentration of 10 micromolar as reflected by an increase of 2.1 days in comparison to wild-type worms.

![Fenofibrate extends lifespan of adult *C. elegans*\
Life span analyses with several hundred N2 wild type nematodes each at three different concentrations of fenofibrate (0.1, 1, and 10 micromolar) versus control (0.1% DMSO).](aging-05-270-g003){#F3}

The effects on maximum life span (80^th^ percentile) were an extension by 4.4 days for bezafibrate (10 micomolar), an extension by 6.1 days for clofibrate (10 micromolar), and an extension by 6.5 days for fenofibrate (0.1 micromolar).

Taken together, these findings indicate that three different fibrates are capable of extending both mean and maximum lifespan of wild type *C. elegans.*

Life span extension through fibrates is PPA-Ralpha/NHR-49 dependent {#s2_2}
-------------------------------------------------------------------

As stated in the introductory section fibrates serve as well-accepted ligands for the mammalian PPARalpha, a nuclear receptor known to heterodimerize with the retinoid-X-receptor (RXR) to promote a number of catabolic processes. The nematodal nuclear hormone receptor 49 (NHR-49) is commonly accepted to serve as a functional orthologue of mammalian PPARalpha since it shares most of the biological activities of the latter \[[@R31]\].

To test the hypothesis whether fibrates act as agonists of PPARalpha and therefore extent life span in *C. elegans*, the life span assays were repeated using two strains that lack functional *nhr-49*, variation ok2165 and variation gk405 (strains RB1716 and VC870, respectively). For this, the most effective life span extending fibrates concentration in wild type, 10 micromolar, was used. Consistent with the hypothesis, clofibrate, bezafibrate, and fenofibrate failed to extend nematodal life span in absence of NHR-49 (Fig. [4A and 4B](#F4){ref-type="fig"}).

![Life span extension through fibrates is NHR-49/PPARalpha-dependent\
**A** Life span analyses with several hundred *nhr-49* knockout nematodes (variation ok2165, strain RB1716) at 10 micromolar bezafibrate, clofibrate, and fenofibrate versus control (0.1% DMSO). **B** Life span analyses with several hundred *nhr-49* knockout nematodes (variation gk405, strain VC870) at 10 micromolar bezafribrate, clofibrate, and fenofibrate versus control (0.1% DMSO).](aging-05-270-g004){#F4}

DISCUSSION {#s3}
==========

To potentially support the ongoing search for compounds that may promote human health especially at higher age, we here show that the fibrates clofibrate, bezafibrate, and fenofibrate induce longevity in a nematodal model organism, the roundworm *C. elegans*. Interestingly, these effects are dependent on the nematodal orthologue of PPARalpha, NHR-49, mediating the promotion of life span.

The *C. elegans* PPARalpha orthologue NHR-49 induces the expression of genes involved in energy metabolism, more precisely in fatty acid beta oxidation (*acs-2*, *ech-1*), desaturation (*fat-5*, *fat-7*), transport, and synthesis of mono-methyl branched-chain fatty acids \[[@R31], [@R32]\]. It remains to be elevated, which of these mechanism are responsible for the life span extending effect of fibrates. Due to stimulation of fatty acid beta oxidation an increase in ROS formation may occur \[[@R33]\], which could promote formation of reactive oxygen species (ROS) in nematodes \[[@R20], [@R23]\]. This increase in ROS may act as a signal to increase stress response and antioxidant defense resulting in longevity resembling an adaptive response signaling process that was named mitochondrial hormesis or mitohormesis \[[@R20], [@R34], [@R35]\]. Based on the current findings, it appears feasible that fibrates act by employing a similar mechanism, especially since it is shown that PPARalpha agonists increase the expression of superoxide dismutase, a major enzyme in antioxidative defense \[[@R36]\].

It is unclear whether our results can be extrapolated to mammals or even humans since the current study has been performed in the model organism *C. elegans*. However, other compounds that have been identified by using a similar, metazoan-based approach have been shown to be effective also in rodents \[[@R11]-[@R19]\].

Summarizing these findings, it is likely that fibrates acting as agonists of PPARalpha to promote health and life span through modulating beta oxidation and ROS formation in a mitohormetic manner, suggesting that these substances may be potential to prevent aging and age-associated diseases also in higher organisms.

METHODS {#s4}
=======

Compounds {#s4_1}
---------

Bezafibrate, clofibrate and fenofibrate were obtained from Sigma-Aldrich (Munich, Germany).

*C. elegans* maintenance {#s4_2}
------------------------

The *C. elegans* strains used were Bristol N2, as well as the mutant strains *nhr-49(ok2165)* and *nhr-49(gk405)*. These were obtained from CGC. Maintenance was performed as previously described \[[@R24]\]. The *E. coli* OP50 strain was used as food source.

Life span assays {#s4_3}
----------------

Compounds were admitted to the agar as previously described \[[@R24]\]. *E.coli* OP50 bacteria were heat-inactivated for 45 minutes as previously described to avoid interference by the xenobiotic-metabolizing activity of E. coli, and used as the only food source \[[@R37]\].
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